SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 384.87 |
| Enterprise Value ($M) | 343.81 |
| Book Value ($M) | 225.85 |
| Book Value / Share | 4.56 |
| Price / Book | 1.70 |
| NCAV ($M) | 202.57 |
| NCAV / Share | 4.09 |
| Price / NCAV | 1.90 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.31 |
| Return on Assets (ROA) | -0.37 |
| Return on Equity (ROE) | -0.42 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 18.76 |
| Current Ratio | 18.76 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 231.79 |
| Assets | 255.07 |
| Liabilities | 29.23 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -84.99 |
| Net Income | -76.41 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -63.85 |
| Cash from Investing | -113.96 |
| Cash from Financing | 97.29 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Citadel Advisors Llc | 7.40 | ||
| 13G/A | Adage Capital Partners Gp, L.l.c. | 8.61 | 98.10 | |
| 13G/A | Eventide Asset Management, Llc | 11.82 | 157.74 | |
| 13D/A | Matrix Capital Management Company, LP | 14.10 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 15,256 | 86,123 | 17.71 | |
| 10,471 | 73,999 | 14.15 | |
| 5,898 | 34,854 | 16.92 | |
| 9,467 | 44,571 | 21.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ATAI – Atai Life Sciences N.V. | ATXS – Astria Therapeutics, Inc. |
| AUPH – Aurinia Pharmaceuticals Inc. | AVBP – ArriVent BioPharma, Inc. |
| AVDL – Avadel Pharmaceuticals plc |
Financial data and stock pages provided by
Fintel.io